ERBB2 and neoplasm: For example, Human Epidermal Receptor – 2 (HER2) positive, oEstrogen Receptor (ER) negative tumours can achieve a pCR rate of up to 90 % [9], while ER positive HER2 negative tumours have pCR rates of less than 20 % [8].